Huntsman: Buy Before The Turn (Rating Upgrade)

Huntsman (HUN) shares have experienced a significant decline over the past year, reflecting broader chemicals sector pressures from weak economic activity, particularly in construction, and persistent oversupply. Despite this, an analyst has upgraded HUN to a 'buy' rating, asserting that much of the negative news is already priced in and highlighting management's effective cost-cutting and restructuring efforts that support liquidity. The upgrade anticipates Huntsman is well-positioned to capitalize on an eventual sector rebound, offering a high yield for patient investors, even as the exact timing of such a recovery remains uncertain.

Analysis

Huntsman (HUN) shares have experienced a severe 50% decline over the past year, reflecting significant cyclical pressures on the chemicals sector, including weak economic activity, a slump in construction, and persistent oversupply. Despite this challenging backdrop, the provided analysis presents a contrarian 'buy' thesis, arguing that the market has already priced in the majority of this negative news. The investment case is supported by proactive management execution on cost-cutting, restructuring, and efficient working capital management, which are bolstering the company's liquidity position. These measures are seen as sufficient to protect the dividend, a key component of the bull case, even amidst current earnings pressure. While Huntsman is positioned to survive the downturn and benefit from an eventual sharp recovery, the primary risk remains the uncertain timing of such a rebound in the sector.

Key Decisions for Investors

• Investors may consider the significant share price depreciation in Huntsman as an opportunity to initiate a position, based on the view that a cyclical bottom is approaching and negative sentiment is already priced in.
• Monitor management's progress on cost reduction and working capital programs, as their success is crucial for sustaining liquidity and the dividend, which is a core part of the 'buy' thesis.
• This investment is best suited for patient investors with a long-term horizon, as the timing for a sector-wide recovery remains the key uncertainty and the high yield is intended to compensate for this waiting period.
• Keep a close watch on leading economic indicators for the construction industry and chemical pricing trends, as these will be the primary catalysts for a potential stock rebound.